Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Thyroid Carcinoma, Anaplastic

NCT02083536 2016-08-10

LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma

Phase 1 Withdrawn

Gynecologic

Ovarian Neoplasms

NCT01245543 2015-11-02

Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Solid Tumors

NCT01562301 2015-06-08

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01938456 2014-07-28

Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer

Phase 1 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00074139 2014-03-05

Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer

Phase 1 Withdrawn

Breast

Breast Neoplasms

Clinical Trials

Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers

Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma

Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer

LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel

S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors

LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma

Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors

Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)

Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer

Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer